Maravai Lifesciences Holdings MRVI
NASDAQ MRVI
$7.32 -0.05 (-0.68%)
At close: Sep 4, 2026 · 4:00 PM EDT

Maravai Lifesciences Holdings (MRVI) Dividend Yield (2020 - 2024)

Analysis

Maravai Lifesciences Holdings (MRVI) Dividend Yield (2020 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Maravai Lifesciences Holdings 1.09 Bn 1.02 Bn 20.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -0.01%
Jun 30, 2024 0.03%
Jun 30, 2023 0.04%
Mar 31, 2023 0.24%
Dec 31, 2022 0.85%
Sep 30, 2022 0.56%
Jun 30, 2022 0.59%
Mar 31, 2022 0.44%
Dec 31, 2021 1.03%
Sep 30, 2021 0.40%
Jun 30, 2021 0.31%
Mar 31, 2021 0.25%
Dec 31, 2020 41.22%